overlay
ML Research Intern
ML + Compchem + Software
hybrid: Burlingame
added Wed Sep 27, 2023
link-outApply to Genesis Therapeutics
Genesis is building a world-class ML team in an industry that has underutilized computational methods for too long. We are creating the best molecular generation and property prediction platform in the world, filling in a critical piece in the drug discovery process. We need you to drive the cutting-edge research that will enable us to find cures for a wider range of diseases, faster than ever before.

You will

  • Drive speed and accuracy improvements in our ML platform, coming up with architecture modifications for 2D and 3D graph neural networks, and rapidly implementing and testing them in pytorch
  • Keep up with deep learning research, especially pertaining to graph neural nets and graph generative models, and quickly prototype ideas gleaned from the literature
  • Dive deep into molecular datasets, creating statistically rigorous train, valid, and test sets to optimally train our models for real-world prediction and generation tasks
  • Develop creative featurizations of 2D and 3D molecular structures that are inspired by laws of physics and chemistry, enabling our networks to take better advantage of available data
  • Work closely with software engineers and medicinal chemists to make our ML platform maximally adaptive to different use cases

You are

  • A strong software engineer who will write code quickly and uphold our code quality standards
  • A deep thinker who reasons from first principles over pattern matching
  • Interested in learning about biochemistry and the drug development process

What we offer

  • The opportunity to work on challenging, high impact ML research that is immediately deployed to accelerate the discovery of new medicines
  • One-on-one mentorship to help guide your research and act as a point person for questions
  • Strong technical coworkers in AI, software, and chemistry, who all have a powerful mix of intellectual curiosity and humility. The team reads and discusses 1-2 ML or chemistry papers every week to stay on top of the field and inspire new ideas
We started Genesis Therapeutics in 2019 with origins in field-leading AI + biophysics research. Since then, we’ve dramatically accelerated innovation in Machine Learning and molecular simulation technologies for drug discovery, with the goal of providing new treatments for patients with severe diseases.
We are a mission-driven group of researchers, engineers, and drug developers. We believe close-knit, interdisciplinary collaboration is crucial for inventing important new technology and rapidly advancing optimal therapies.